Evidence mapPaperPMID 38022578Full record

ReviewFrontiers in immunology2023

The impact of inflammation and acute phase activation in cancer cachexia.

Tyler P Robinson, Tewfik Hamidi, Brittany Counts, Denis C Guttridge, Michael C Ostrowski, Teresa A Zimmers, Leonidas G Koniaris

Open access · goldAbstract readReview
In one paragraph

Review in Frontiers in immunology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed, 1 pooled it
5.1field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 1 synthesis or guideline pooled it, 29 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Observational
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Hallmarks of Cancer Cachexia: Sexual Dimorphism in Related Pathways.International journal of molecular sciences · 2025
    Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Exploring heterogeneity: a dive into preclinical models of cancer cachexia.American journal of physiology. Cell physiology · 2024
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 1 country.

Tyler P RobinsonDepartment of Surgery, Indiana University School of Medicine, Indianapolis, IN, United States.
Tewfik HamidiDepartment of Surgery, Oregon Health Sciences University, Portland, OR, United States.
Brittany CountsDepartment of Surgery, Oregon Health Sciences University, Portland, OR, United States.
Denis C GuttridgeHollings Cancer Center, Medical University of South Carolina, Charleston, SC, United States.
Michael C OstrowskiHollings Cancer Center, Medical University of South Carolina, Charleston, SC, United States.
Teresa A ZimmersDepartment of Surgery, Indiana University School of Medicine, Indianapolis, IN, United States.
Leonidas G KoniarisDepartment of Surgery, Oregon Health Sciences University, Portland, OR, United States.
Oregon Health & Science University · USMUSC Hollings Cancer Center · USIndiana University – Purdue University Indianapolis · USIndiana University School of Medicine

Funding

The role of the macroenvironment in pancreatic cancer-induced cachexiaP01CA236778 · MEDICAL UNIVERSITY OF SOUTH CAROLINA · 2025 to 2025
$1.9M
NCI NIH HHS P01 CA236778NIGMS NIH HHS R01 GM137656
6 · The paper itself

Abstract

The development of cachexia in the setting of cancer or other chronic diseases is a significant detriment for patients. Cachexia is associated with a decreased ability to tolerate therapies, reduction in ambulation, reduced quality of life, and increased mortality. Cachexia appears intricately linked to the activation of the acute phase response and is a drain on metabolic resources. Work has begun to focus on the important inflammatory factors associated with the acute phase response and their role in the immune activation of cachexia. Furthermore, data supporting the liver, lung, skeletal muscle, and tumor as all playing a role in activation of the acute phase are emerging. Although the acute phase is increasingly being recognized as being involved in cachexia, work in understanding underlying mechanisms of cachexia associated with the acute phase response remains an active area of investigation and still lack a holistic understanding and a clear causal link. Studies to date are largely correlative in nature, nonetheless suggesting the possibility for a role for various acute phase reactants. Herein, we examine the current literature regarding the acute phase response proteins, the evidence these proteins play in the promotion and exacerbation of cachexia, and current evidence of a therapeutic potential for patients.

Indexed as

CachexiaNeoplasmsAcute-Phase ProteinsAcute-Phase ReactionHumansInflammationQuality of LifeAcute-Phase Proteinsacute phase reactantacute phase responsecachexiacancerchronic diseasenegative acute phase reactantpositive acute phase reactant

Identifiers

PMID38022578
PMCPMC10644737
OpenAlexW4388078284

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.